PMN

$3.20-6.16%visit website

ProMIS Neurosciences Inc.

Market Cap

$29M

Live price × SEC shares (Aug 13, 2026)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

-0.21

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

0.6

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Research & development	9,797	9,368	6,971	9,522	35,658
Total operating expenses	11,750	10,772	8,645	12,266	43,434
Operating income	(11,750)	(10,772)	(8,645)	(12,266)	(43,434)
Net income	(11,580)	(10,674)	(8,244)	(11,730)	(42,228)
EPS (basic) ($)	(0.24)		(1.26)	(1.28)	—
EPS (diluted) ($)	(0.24)		(1.26)	(1.28)	—
Weighted avg. shares (basic)	48,834		6,528	9,142
Weighted avg. shares (diluted)	48,834		6,528	9,142

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 17 more quarters, back to Jun 2021, with Tormere Pro.

Corporate Events (8-K)

10 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Aug 13, 2026 accepted 8:07 PM ET	2.02Earnings release	Document SEC ↗
Jul 28, 2026 accepted 10:05 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
May 20, 2026 accepted 8:30 PM ET	5.02Officer / director change5.07Shareholder vote	Document SEC ↗
May 12, 2026 accepted 10:45 AM ET	2.02Earnings release	Document SEC ↗
Mar 25, 2026 accepted 12:06 PM ET	2.02Earnings release	Document SEC ↗
Jan 30, 2026 accepted 1:25 PM ET	1.01Material agreement3.02Unregistered equity sale8.01Other events	Document SEC ↗
Dec 16, 2025 accepted 9:48 PM ET	8.01Other events	Document SEC ↗
Nov 24, 2025 accepted 1:30 PM ET	5.03Bylaws / fiscal year8.01Other events	Document SEC ↗
Nov 19, 2025 accepted 2:25 PM ET	5.07Shareholder vote	Document SEC ↗
Nov 12, 2025 accepted 12:05 PM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

39%

W/W -41.2pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

6.58x

Avg Daily Buying (90d)

126 sh/day

Baseline Daily Buying

47.5 sh/day

Unique Buyers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-11-02	2026-11-03	Cashman Neil	Director & Chief Scientific Officer	Purchase	10.0K	$3.86	$39K	14.5K	View
2026-10-30	2026-11-03	Williams Eugene	Director	Purchase	1,316	$3.99	$5K	13.7K	View
2026-08-05	2026-08-07	Kaplan Johanne	Chief Development Officer	Purchase	2,280	$13.30	$30K	6,221	View
2026-04-22	2026-04-23	Kirwin Patrick D.	Director	Purchase	4,000	$11.33	$45K	4,653	View
2026-03-05	2026-03-06	Williams Eugene	Director	Purchase	2,000	$24.40	$49K	12.4K	View

1–5 of 9

1 / 2

Recent News

ProMIS Neurosciences, Inc. (PMN) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-11-04

Nasdaq Unusual-Volume Movers for Nov. 3, 2026

ChartMill · 2026-11-03

Can Pharmacy Growth Offset Evernorth's Profit Decline in Cigna's Q3?

Yahoo · 2026-11-03

ProMIS Neurosciences to Report Third Quarter 2026 Financial Results and Business Update on November 12, 2026

Yahoo · 2026-11-03

A webcast is set for ProMIS’ third-quarter results call on Nov. 12 at 4:30 p.m. ET.

Stock Titan · 2026-11-03

Roth Capital Maintains Buy on ProMIS Neurosciences, Lowers Price Target to $15

Benzinga · 2026-11-02

Is ProMIS Neurosciences (NASDAQ:PMN) Stock Recovering After a 12.39 Percent Pre-Market Advance?

Kalkine · 2026-11-02

$PMN stock is down 49% today. Here's what we see in our data.

Quiver Quantitative · 2026-10-30

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · 2026-10-30

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga · 2026-10-30

Wall Street Analysts Believe Promis Neurosciences (PMN) Could Rally 292.95%: Here's is How to Trade

Yahoo · 2026-10-29

Will HCA Healthcare's Q3 Earnings Benefit From Higher Admissions?

Yahoo · 2026-10-22

12 Health Care Stocks Moving In Wednesday's Intraday Session

Benzinga · 2026-10-21

Can Higher Admissions Offset Rising Costs in UHS' Q3 Earnings?

Yahoo · 2026-10-21

ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer

Yahoo · 2026-10-06

Informational purposes only, not investment advice.

PMN

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

ProMIS Neurosciences Inc. (PMN)

Reporting Insiders

Factor Profile

Corporate Events (8-K)

Date	Insider	Type	Shares	Value
2026-11-02	Cashman Neil	P	10,000	$38,600
2026-10-30	Williams Eugene	P	1,316	$5,250.84
2026-08-05	Kaplan Johanne	P	2,280	$30,324
2026-04-22	Kirwin Patrick D.	P	4,000	$45,320
2026-03-05	Williams Eugene	P	2,000	$48,800